TITLE

CHIH-DFT determination of the molecular structure infrared spectra, UV spectra and chemical reactivity of three antitubercular compounds: Rifampicin, Isoniazid and Pyrazinamide

AUTHOR(S)
Alejandra Favila; Marco Gallo; Daniel Glossman-Mitnik
PUB. DATE
April 2007
SOURCE
Journal of Molecular Modeling;Apr2007, Vol. 13 Issue 4, p505
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract??Three of the most frequent antitubercular agents employed against Mycobacterium tuberculosis are: Rifampicin, Isoniazid and Pyrazinamide. It has been proven that the use of these antitubercular agents together, shortens the treatment period from 12?18?months to 6?months [1]. In this work we use a new Density Functional Theory chemistry model called CHIH-DFT (Chihuahua-Heterocycles-Density Functional Theory) that reflects the mixture of Hartree Fock exchange and DFT exchange, according to a mixing parameter based on empirical rules suited for heterocyclic systems. This new chemistry model was used to calculate the molecular structure of these antitubercular compounds, as well as their infrared, UV spectra, chemical reactivity and electronic properties. The UV and infrared spectra were obtained by experimental techniques. The calculated molecular structure, UV and IR spectra values from CHIH-DFT were compared with experimentally obtained values and theoretical studies. These results are in good agreement with experimental and theoretical studies. We also predicted using the relative electrophilicity and relative nucleophilicity concepts as defined by Roy et al. [2] the chemical active sites for the three antitubercular compounds as well as their electronegativity, ionization potential, electron affinity, hardness, dipole moment, EHOMO-ELUMOgap energy, etc.
ACCESSION #
24397086

 

Related Articles

  • Gatifloxacin in combination with rifampicin in a murine tuberculosis model. Michael Cynamon; Mary R. Sklaney; Carolyn Shoen // Journal of Antimicrobial Chemotherapy (JAC);Aug2007, Vol. 60 Issue 2, p429 

    Objectives Gatifloxacin previously demonstrated good in vitro and in vivo activities against Mycobacterium tuberculosis. Several regimens of gatifloxacin in combination with rifampicin were compared with isoniazid plus rifampicin in a mouse tuberculosis model. Methods C57BL/6 mice were infected...

  • Combined drug medium with isoniazid and rifampicin for identification of multi-drug resistant Mycobacterium tuberculosis. Nalini, S.; Lakshmi, R.; Devika, K.; Ravikumar, D.; Ramachandran, R. // Indian Journal of Medical Microbiology;Apr2010, Vol. 28 Issue 2, p162 

    A low-cost method of detecting multi-drug resistant Mycobacterium tuberculosis (MDR-TB) with the possibility of quick adoption in a resource limited setting is urgently required. We conducted a study combining isoniazid and rifampicin in a single LJ medium, to detect MDR-TB strains. Combined and...

  • Synthesis and Anti-Mycobacterial Activity of N'-[(E)-(Disubstituted- Phenyl)Methylidene]Isonicotino-Hydrazide Derivatives. Junior, Ivan N.; Lourençco, Maria C. S.; Henriques, Maria das Graças M. O.; Ferreira, Barbara; Vasconcelos, Thatyana R. A.; Peralta, Mônica A.; de Oliveira, Pedro S. M.; Wardell, Solange M. S. V.; de Souza, Marcus V. N. // Letters in Drug Design & Discovery;Nov2005, Vol. 2 Issue 7, p563 

    A series of eight N'-[(E)-(disubstituted-phenyl)methylidene]isonicotino-hydrazide derivatives were synthesized and evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis, and the activity expressed as the minimum inhibitory concentration (MIC) in mg/mL. Four...

  • Pre-Existing Isoniazid Resistance, but Not the Genotype of Mycobacterium Tuberculosis Drives Rifampicin Resistance Codon Preference in Vitro. Bergval, Indra; Kwok, Brian; Schuitema, Anja; Kremer, Kristin; van Soolingen, Dick; Klatser, Paul; Anthony, Richard // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Both the probability of a mutation occurring and the ability of the mutant to persist will influence the distribution of mutants that arise in a population. We studied the interaction of these factors for the in vitro selection of rifampicin (RIF)-resistant mutants of Mycobacterium tuberculosis....

  • Role of Human Neutrophil Peptide--1 as a Possible Adjunct to Antituberculosis Chemotherapy. Kalita, Anjana; Verma, Indu; Khuller, G. K. // Journal of Infectious Diseases;10/15/2004, Vol. 190 Issue 8, p1476 

    We report the role of human neutrophil peptide (HNP)-1 as an adjunct to antituberculosis (anti-TB) drugs. The combination of HNP-1, isoniazid, and rifampicin was evaluated against Mycobacterium tuberculosis H37Rv in vitro, ex vivo, and in vivo, and synergism was observed on the basis of...

  • Drug-susceptibility Patterns of Mycobacterium tuberculosis in Mpumalanga Province, South Africa: Possible Guiding Design of Retreatment Regimen. Green, E.; Obi, C. L.; Nchabeleng, M.; De Villiers, B. E.; Sein, P. P.; Letsoalo, T.; Hoosen, A. A.; Bessong, P. O.; Ndip, R. N. // Journal of Health, Population & Nutrition;Feb2010, Vol. 28 Issue 1, p7 

    Multidrug-resistant tuberculosis (MDR-TB) has been a cause of concern in both developed and developing countries. The prevalence of drug resistance in Mycobacterium tuberculosis (MTB) isolates (n=692) from Mpumalanga province was assessed. In total, 692 (64%) MTB strains from cases with...

  • Primary Drug Resistance and Molecular Epidemiology of the Mycobacterium tuberculosis Strains Isolated in the Kelkit Valley. Bulut, Yunus; Yenişehirli, Gülgün; Otlu, Baris; Seyfikli, Zehra; Celikel, Serhat; Yilmaz, Ayşe; Inönü, Handan // Turkish Journal of Medical Sciences;2009, Vol. 39 Issue 1, p101 

    Aim: The aim of this study was to determine the primary drug resistance rates and genotypes of resistant Mycobacterium tuberculosis strains isolated in the Kelkit Valley. Materials and Methods: Primary resistance to isoniazid (INH), rifampicin (RIF), ethambutol (ETB), and streptomycin (SM) was...

  • Discordance in Mycobacterium tuberculosis Rifampin Susceptibility. Kalokhe, Ameeta S.; Shafiq, Majid; Lee, James C.; Metchock, Beverly; Posey, James E.; Ray, Susan M.; Anderson, Albert; Wang, Yun F.; Nguyen, Minh Ly T. // Emerging Infectious Diseases;Mar2012, Vol. 18 Issue 3, p537 

    The article discusses the case of a 45-year-old homeless woman with acquired immune deficiency syndrome (AIDS) who experienced pulmonary tuberculosis (TB) relapse with an associated resistance to antituberculous drugs isoniazid (INH) and rifampin (RIF). Her symptoms included fever, night sweats,...

  • Derivatives of 3-Isoxazolecarboxylic Acid Esters - A Potent and Selective Compound Class against Replicating and Nonreplicating Mycobacterium tuberculosis. Lilienkampf, Annamaria; Pieroni, Marco; Franzblau, Scott G.; Bishai, William R.; Kozikowski, Alan P. // Current Topics in Medicinal Chemistry;Apr2012, Vol. 12 Issue 7, p729 

    New antituberculosis (anti-TB) drugs are urgently needed to battle drug-resistant Mycobacterium tuberculosis (Mtb) strains and to shorten the long treatment regimen. A series of isoxazole-based compounds, bearing a carboxy moiety at the C3 position, are highly potent and versatile anti-TB...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics